Table 1.
Groupa | Anaplasma spp. antibodies (%) (n = 425) | A. platys (%) (n = 362) | Anaplasma spp. and A. platys (%) (n = 362) | |||
---|---|---|---|---|---|---|
Positive | Negative | Positive | Negative | Not available | ||
Group I (n = 95) | 11 (2.6) | 84 (19.8) | 3 (0.8) | 88 (24.3) | 4 | 1 (0.3) |
Group Ia (n = 63) | 7 (1.6) | 56 (13.2) | 2 (0.5) | 57 (15.7) | 4 | 0 (0.0) |
Group Ib (n = 32) | 4 (0.9) | 28 (6.6) | 1 (0.3) | 31 (8.6) | 0 | 1 (0.3) |
Group II (n = 160) | 45 (10.6) | 115 (27.1) | 4 (1.1) | 100 (27.6) | 56 | 1 (0.3) |
Group III (n = 170) | 37 (8.7) | 133 (31.3) | 20 (5.5) | 147 (40.7) | 3 | 9 (2.3) |
Total (n = 425) | 93 (21.9) | 332 (78.1) | 27 (7.5) | 335 (92.5) | 63 | 11 (3.0) |
aGroup I: urban client-owned dogs sample in the VTH; Group Ia: urban client-owned dogs sample in the VTH without clinical signs compatible with a TBD; Group Ib: urban client-owned dogs sample in the VTH with clinical signs compatible with a TBD; Group II: rural client-owned dogs; Group III: military and gendarmerie working dogs